Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DORIA

Showing results (291-300 of 667) with videos related to

Pageof 67
Sort By:
Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.
Nature Communications|May 21, 2024
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strainsShixia Wang, Kun-Wei Chan, Danlan Wei, et al.
Cell Reports|March 14, 2024
Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolutionMichelle K Tenggara, Seo-Ho Oh, Catherine Yang, et al.
Annals of the Rheumatic Diseases|July 27, 2016
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeL Andreoli, G K Bertsias, N Agmon-Levin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibodyBharat Madan, Baoshan Zhang, Kai Xu, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variantSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
ACS Infectious Diseases|February 17, 2018
Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric AntigensIvelin S Georgiev, Michael Gordon Joyce, Rita E Chen, et al.
Scientific Reports|May 19, 2022
Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potencyCindy X Cai, Nicole A Doria-Rose, Nicole A Schneck, et al.
Cell Reports|April 30, 2020
HIV-1 Envelope and MPER Antibody Structures in Lipid AssembliesKimmo Rantalainen, Zachary T Berndsen, Aleksandar Antanasijevic, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Pageof 67

Showing results (291-300 of 667) with videos related to

Sort By:
Pageof 67
Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.
Nature Communications|May 21, 2024
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strainsShixia Wang, Kun-Wei Chan, Danlan Wei, et al.
Cell Reports|March 14, 2024
Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolutionMichelle K Tenggara, Seo-Ho Oh, Catherine Yang, et al.
Annals of the Rheumatic Diseases|July 27, 2016
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeL Andreoli, G K Bertsias, N Agmon-Levin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibodyBharat Madan, Baoshan Zhang, Kai Xu, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variantSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
ACS Infectious Diseases|February 17, 2018
Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric AntigensIvelin S Georgiev, Michael Gordon Joyce, Rita E Chen, et al.
Scientific Reports|May 19, 2022
Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potencyCindy X Cai, Nicole A Doria-Rose, Nicole A Schneck, et al.
Cell Reports|April 30, 2020
HIV-1 Envelope and MPER Antibody Structures in Lipid AssembliesKimmo Rantalainen, Zachary T Berndsen, Aleksandar Antanasijevic, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Pageof 67